Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen

Rany M. Salem(University of California San Diego), Jennifer N. Todd(Broad Institute), Niina Sandholm(University of Helsinki), Joanne B. Cole(Broad Institute), Wei‐Min Chen(University of Virginia), Darrell Andrews(University College Dublin), Marcus G. Pezzolesi(University of Utah), Paul McKeigue(Institute of Population and Public Health), Linda T. Hiraki(Hospital for Sick Children), Chengxiang Qiu(University of Pennsylvania), Viji Nair(University of Michigan), Chen Di Liao(Hospital for Sick Children), Jing Cao(Hospital for Sick Children), Erkka Valo(University of Helsinki), Suna Önengüt-Gümüşcü(University of Virginia), Adam M. Smiles(Joslin Diabetes Center), Stuart J. McGurnaghan(Institute of Genetics and Cancer), Jani K. Haukka(University of Helsinki), Valma Harjutsalo(University of Helsinki), Eoin Brennan(University College Dublin), Natalie R. van Zuydam(Centre for Human Genetics), Emma Ahlqvist(Lund University), Ross Doyle(University College Dublin), Tarunveer S. Ahluwalia(Steno Diabetes Centers), Maria Lajer(Steno Diabetes Centers), Maria Hughes(University College Dublin), Jihwan Park(University of Pennsylvania), Jan Skupień(Joslin Diabetes Center), Athina Spiliopoulou(Institute of Population and Public Health), Andy Liu(University of Michigan), Rajasree Menon(University of Michigan), Carine M. Boustany‐Kari(Boehringer Ingelheim (Brazil)), Hyun Mi Kang(University of Michigan), Robert G. Nelson(National Institutes of Health), Ronald Klein(University of Wisconsin–Madison), Ronald Klein(University of Wisconsin–Madison), Kristine E. Lee(University of Wisconsin–Madison), Xiaoyu Gao(University of Wisconsin–Madison), Michael Mauer(University of Minnesota), Silvia Maestroni(Vita-Salute San Raffaele University), Maria Luiza Caramori(University of Minnesota), Ian H. de Boer(University of Washington), Rachel G. Miller(University of Pittsburgh), Jingchuan Guo(University of Pittsburgh), Andrew P. Boright(Hospital for Sick Children), David‐Alexandre Trégouët(Inserm), Beata Gyorgy(Inserm), Janet K. Snell‐Bergeon(University of Colorado Denver), David M. Maahs(Stanford University), Shelley B. Bull(University of Toronto), Angelo J. Canty(McMaster University), Colin N.A. Palmer(University of Dundee), Lars Stechemesser(Paracelsus Medical University), Bernhard Paulweber(Paracelsus Medical University), Raimund Weitgasser(Paracelsus Medical University), Jeļizaveta Sokolovska(University of Latvia), Vita Rovīte(Latvian Biomedical Research and Study Centre), Valdis Pīrāgs(Pauls Stradiņš Clinical University Hospital), Edita Prakapienė(Military Medical Academy), Lina Radzevičienė(Lithuanian University of Health Sciences), Rasa Verkauskienė(Lithuanian University of Health Sciences), Nicolae Mircea Panduru(University of Helsinki), Leif C. Groop(University of Helsinki), Mark I. McCarthy(Centre for Human Genetics), Harvest F. Gu(China Pharmaceutical University), Anna Möllsten(Umeå University), Henrik Falhammar(Karolinska University Hospital), Kerstin Brismar(Karolinska University Hospital), Finian Martin(University College Dublin), Peter Rossing(University of Copenhagen), Tina Costacou(University of Pittsburgh), Gianpaolo Zerbini(Vita-Salute San Raffaele University), Michel Marre(Inserm), Samy Hadjadj(Centre National de la Recherche Scientifique), Amy Jayne McKnight(Queen's University Belfast), Carol Forsblom(Folkhälsans Forskningscentrum), Gareth J. McKay(Queen's University Belfast), Catherine Godson(University College Dublin), Alexander P. Maxwell(Queen's University Belfast), Matthias Kretzler(University of Michigan), Katalin Suszták(University of Pennsylvania), Helen M. Colhoun(Institute of Genetics and Cancer), Andrzej S. Królewski(Joslin Diabetes Center), Andrew D. Paterson(Hospital for Sick Children), Per‐Henrik Groop(University of Helsinki), Stephen S. Rich(University of Virginia), Joel N. Hirschhorn(Broad Institute), José C. Florez(Broad Institute)
Journal of the American Society of Nephrology
September 19, 2019
Cited by 213Open Access
Full Text

Abstract

Significance Statement Although studies show that diabetic kidney disease has a heritable component, searches for the genetic determinants of this complication of diabetes have had limited success. In this study, a new international genomics consortium, the JDRF funded Diabetic Nephropathy Collaborative Research Initiative, assembled nearly 20,000 samples from participants with type 1 diabetes, with and without kidney disease. The authors found 16 new diabetic kidney disease–associated loci at genome-wide significance. The strongest signal centers on a protective missense coding variant at COL4A3 , a gene that encodes a component of the glomerular basement membrane that, when mutated, causes the progressive inherited nephropathy Alport syndrome. These GWAS-identified risk loci may provide insights into the pathogenesis of diabetic kidney disease and help identify potential biologic targets for prevention and treatment. Background Although diabetic kidney disease demonstrates both familial clustering and single nucleotide polymorphism heritability, the specific genetic factors influencing risk remain largely unknown. Methods To identify genetic variants predisposing to diabetic kidney disease, we performed genome-wide association study (GWAS) analyses. Through collaboration with the Diabetes Nephropathy Collaborative Research Initiative, we assembled a large collection of type 1 diabetes cohorts with harmonized diabetic kidney disease phenotypes. We used a spectrum of ten diabetic kidney disease definitions based on albuminuria and renal function. Results Our GWAS meta-analysis included association results for up to 19,406 individuals of European descent with type 1 diabetes. We identified 16 genome-wide significant risk loci. The variant with the strongest association (rs55703767) is a common missense mutation in the collagen type IV alpha 3 chain ( COL4A3) gene, which encodes a major structural component of the glomerular basement membrane (GBM). Mutations in COL4A3 are implicated in heritable nephropathies, including the progressive inherited nephropathy Alport syndrome. The rs55703767 minor allele (Asp326Tyr) is protective against several definitions of diabetic kidney disease, including albuminuria and ESKD, and demonstrated a significant association with GBM width; protective allele carriers had thinner GBM before any signs of kidney disease, and its effect was dependent on glycemia. Three other loci are in or near genes with known or suggestive involvement in this condition ( BMP7) or renal biology ( COLEC11 and DDR1 ). Conclusions The 16 diabetic kidney disease–associated loci may provide novel insights into the pathogenesis of this condition and help identify potential biologic targets for prevention and treatment.


Related Papers

No related papers found

Powered by citation graph analysis